Chemoinformaics analysis of 6-O-alpha-l-arabinofuranosyl-beta-d-glucopyranose
| Molecular Weight | 312.271 | nRot | 4 |
| Heavy Atom Molecular Weight | 292.111 | nRig | 11 |
| Exact Molecular Weight | 312.106 | nRing | 2 |
| Solubility: LogS | 0.017 | nHRing | 2 |
| Solubility: LogP | -3.139 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 39.7259 |
| nHD | 7 | BPOL | 25.2721 |
| QED | 0.267 |
| Synth | 4.189 |
| Natural Product Likeliness | 2.409 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.835 |
| HIA | 0.98 |
| CACO-2 | -5.817 |
| MDCK | 0.000387673 |
| BBB | 0.437 |
| PPB | 0.140861 |
| VDSS | 0.309 |
| FU | 0.702137 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.024 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.093 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.108 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.002 |
| CL | 1.224 |
| T12 | 0.623 |
| hERG | 0.045 |
| Ames | 0.207 |
| ROA | 0.207 |
| SkinSen | 0.022 |
| Carcinogencity | 0.015 |
| EI | 0.012 |
| Respiratory | 0.016 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.750659 |